SCHEMBL6457901

SCHEMBL6457901

CC(=O)OC1CCC(CN)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.47
PLG P00747 1/20 0.47
PLAT P00750 1/20 0.47
TPSAB1 Q15661 1/20 0.41
TPSD1 Q9BZJ3 1/20 0.41
TPSG1 Q9NRR2 1/20 0.41
NCF1 P14598 1/20 0.35
CYP2D6 P10635 2/20 0.35
CYP19A1 P11511 1/20 0.34
CHRM2 P08172 5/20 0.33
CHRM1 P11229 3/20 0.33
CHRM4 P08173 2/20 0.33
CHRM5 P08912 2/20 0.33
CHRM3 P20309 2/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
EPHX1 P07099 1/20 0.32
F2 P00734 1/20 0.32
DHCR24 Q15392 1/20 0.32
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19924308 0.83 PLG (0.50) LMNAPLGPLATTPSAB1TPSD1
SCHEMBL12476221 0.82 CHRM2 (0.42) LMNACYP2D6CHRM2CHRM1CHRM4
SCHEMBL177205 0.82
SCHEMBL13888364 0.81 PLG (0.41) LMNAPLGPLATTPSAB1TPSD1
SCHEMBL28726529 0.81 PLG (0.48) LMNAPLGPLATTPSAB1TPSD1
SCHEMBL28563130 0.81 PLG (0.48) LMNAPLGPLATTPSAB1TPSD1
SCHEMBL9506281 0.81 PLG (0.54) LMNAPLGPLATTPSAB1TPSD1
SCHEMBL15712634 0.81 CYP19A1 (0.49) LMNACYP2D6CYP19A1CHRM2CHRM1
SCHEMBL28563135 0.81 PLG (0.48) LMNAPLGPLATTPSAB1TPSD1
SCHEMBL9505982 0.81 PLG (0.54) LMNAPLGPLATTPSAB1TPSD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3700595-B1 KITS FOR ANCHORING IMPLANTABLE MEDICAL DEVICES MEDTRONIC INC (US) 2024-06-19 EP disclosed
CN-114181077-B Method for synthesizing tranexamic acid 风火轮(上海)生物科技有限公司 2024-02-27 CN disclosed
US-11191878-B2 Kits for local delivery of water soluble agents and methods of use MEDTRONIC, INC. (US) 2021-12-07 US disclosed
US-20200345901-A1 KITS FOR LOCAL DELIVERY OF WATER SOLUBLE AGENTS AND METHODS OF USE MEDTRONIC, INC. (US) 2020-11-05 US disclosed
EP-3700595-A1 KITS FOR ANCHORING IMPLANTABLE MEDICAL DEVICES Medtronic, Inc. (US) 2020-09-02 EP disclosed
US-10736998-B2 Kits for local delivery of water soluble agents and methods of use MEDTRONIC, INC. (US) 2020-08-11 US disclosed
US-20190262510-A1 KITS FOR LOCAL DELIVERY OF WATER SOLUBLE AGENTS AND METHODS OF USE MEDTRONIC, INC. (US) 2019-08-29 US disclosed
US-10314951-B2 Kits for local delivery of water soluble agents and methods of use MEDTRONIC, INC. (US) 2019-06-11 US disclosed
US-20190125938-A1 KITS FOR LOCAL DELIVERY OF WATER SOLUBLE AGENTS AND METHODS OF USE TYRX, INC. (US) 2019-05-02 US disclosed
US-10034969-B1 Kits for local delivery of water soluble agents and methods of use TYRX, INC. (US) 2018-07-31 US disclosed
US-9987400-B1 Kits for local delivery of water soluble agents and methods of use TYRX, INC. (US) 2018-06-05 US disclosed
US-9919080-B1 Kits for local delivery of water soluble agents and methods of use TYRX, INC. (US) 2018-03-20 US disclosed
CN-105026407-B Beta-lactamase inhibitors 维纳拓尔斯制药公司 2017-09-08 CN disclosed
EP-1534700-A1 NOVEL THIOPHENE DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME WARNER-LAMBERT COMPANY LLC (US) 2005-06-01 EP disclosed
WO-2004018448-A1 NOVEL THIOPHENE DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME WARNER-LAMBERT COMPANY LLC (US) 2004-03-04 WO disclosed